The Cabinet Committee on Economic Affairs has approved a proposal of the Ministry of Health & Family Welfare for establishment of an Integrated Vaccine Complex (IVC) at Chengalpattu, Kanchipuram district (Tamil Nadu), according to a press notification dated 26 April.
The complex will be
established by the public sector firm, HLL Life Care Limited, an undertaking of the
Ministry, at an estimated cost of Rs. 594 crore. The project is likely to be
completed by 2014.
The complex shall be the nodal center for research, manufacture and supply of vaccines at affordable prices for the Universal Immunization Programme (UIP) of the Government of India. The vaccines to be manufactured in the IVC are pentavalent combination (DPT plus Hep B plus Hib), BCG, measles, Hepatitis B, Human Rabies, Hib and Japanese Encephalitis vaccine.
The complex shall be the nodal center for research, manufacture and supply of vaccines at affordable prices for the Universal Immunization Programme (UIP) of the Government of India. The vaccines to be manufactured in the IVC are pentavalent combination (DPT plus Hep B plus Hib), BCG, measles, Hepatitis B, Human Rabies, Hib and Japanese Encephalitis vaccine.
The annual capacity of IVC
is expected to be around 585 million doses. The vaccines manufactured in the
IVC complex are proposed to meet about 75% of the total requirement of vaccines
covered under the UIP and shall be able to meet the requirements of the major
disease preventable vaccines in the country to a large extent.
The project is of national importance and will provide vaccine security and consequently the health security of the nation. Vaccines produced in the complex shall be utilized for immunization of pregnant women, infants and small children against various diseases throughout the country.
No comments:
Post a Comment